Tumor necrosis factor in the heart

American Journal of Physiology

Volumn 274, Issue 3 PART 2, 1998, Pages

  Meldrum, Daniel R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Heat shock proteins; Ischemia and reperfusion; Lipopolysaccharide; Mitogen activated protein kinase; Myocardium; Nuclear factor kappa b

Indexed keywords

HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR BINDING PROTEIN;

CLINICAL MEDICINE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GRAFT REJECTION; HEART FAILURE; HEART GRAFT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; MACROPHAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEPSIS;

ADENOSINE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CALCIUM; HEART; HEAT-SHOCK PROTEINS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MACROPHAGES; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NOREPINEPHRINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031918203     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.3.r577     Document Type: Article

References (308)

1. Abraham, E. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. Second Annual Autumnal Sepsis Meeting, Deauville, France, 1995.
2. Abraham, E., M. P. Glauser, T. Butler, J. Garbino, D. Gelmont, P. F. Laterre, K. Kudsk, H. A. B. Ha, C. Otto, E. Tobin, C. Zwingelstein, W. Lesslauer, and A. Leighton. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277:1531-1538, 1997.
3. Abraham, E., and T. A. Raffin. Sepsis therapy trials: continued disappointment or reason for hope? JAMA 271:1876-1878, 1994.
4. Abraham, E., R. Wunderink, H. Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R. P. Wenzel, R. Balk, R.
5. Allred, J. E. Pennington, and J. C. Wherry. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 273: 934-941, 1995.
6. Aderka, D., J. Le, and J. Vilcek. IL-6 inhibits LPS-induced tumor necrosis factor production in cultured human monocytes, in U937 cells, and in mice. J. Immunol. 143:3517-3523, 1989.
7. 3, in plasma after experimental myocardial infarction. J. Mol. Cell. Cardiol. 29: 1-9, 1997.
8. Alexander, H. R., G. G. H. Wong, G. M. Doherty, D. J. Venzon, D. L. Fraker, and J. A. Norton. Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with IL-1 and TNF. J. Exp. Med. 175:1139-1142, 1992.
9. Amiot, F., O. Boussadia, S. Cases, C. Fitting, M. Lebastard, J. M. Cavaillon, G. Milon, and F. Dautry. Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage. Eur. J. Immunol. 27:1035-1042, 1997.
10. Andreotti, F., V. Pasceri, D. R. Hackett, G. J. Davies, A. W. Haider, and A. Maseri. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N. Engl. J. Med. 334: 7-12, 1996.
11. Arras, M., A. Hoche, R. Bohle, P. Eckert, W. Riedel, and J. Schaper. Tumor necrosis factor-alpha in macrophages of heart, liver, kidney, and in the pituitary gland. Cell Tissue Res. 285: 39-49, 1996.
12. Ayala, A., C. D. Herndon, D. L. Lehman, C. A. Ayala, and I. H. Chaudry. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261-4275, 1996.
13. Ayala, A., J. M. Kisala, J. A. Felt, M. M. Perrin, and I. H. Chaudry. Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis? Arch. Surg. 127: 191-197, 1992.
14. Ayala, A., D. R. Meldrum, M. M. Perrin, and I. H. Chaudry. The release of transforming growth factor beta following hemorrhage: its role as a mediator of host immunosuppression. Immunology 79:479-484, 1993.
15. Ayala, A., M. M. Perrin, D. R. Meldrum, W. Ertel, and I. H. Chaudry. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2:170-174, 1990.
16. Banerjee, A., C. Locke-Winter, K. B. Rogers, M. B. Mitchell, D. D. Bensard, E. C. Brew, C. B. Cairns, and A. H. Harken. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1 adrenergic mechanism. Circ. Res. 73:656-670, 1993.
17. Barnes, P. J., and M. Karvin. Nuclear factor kappa B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071, 1997.
18. Bazzoni, F., and B. Beutler. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725, 1996.
19. Benigni, F., S. Sacco, D. Pennica, and P. Ghezzi. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of LPS-treated mice and in vitro mouse blood cells. Am. J. Pathol. 149:1847-1850, 1996.
20. Benigni, F., P. Villa, M. T. Dimitri, S. Sacco, J. D. Sipe, L. Lagunowich, N. Panayotatos, and P. Ghezzi. Ciliary neurotrophic factor (CNTF) inhibits brain and peripheral TNF production and, in association with its soluble receptor, protects mice against LPS toxicity. Mol. Med. 1: 568-575, 1995.
21. Bensard, D. B., J. M. Brown, B. O. Anderson, A. Banerjee, P. F. Shanley, M. A. Grosso, G. J. R. Whitman, and A. H. Harken. Induction of endogenous tissue antioxidant enzyme activity attenuates myocardial reperfusion injury. J. Surg. Res. 49:126-131, 1990.
22. Bensard, D. D., A. Banerjee, R. C. Mclntyre, R. Berens, and A. H. Harken. Endotoxin disrupts beta-adrenergic signal transduction in the heart. Arch. Surg. 129:198-205, 1994.
23. Beutler, B., and A. Cerami. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316: 379-385, 1987.
24. Beutler, B., D. Greenwald, J. D. Kulmes, M. Chang, Y. C. Pan, J. Mathison, R. Ulevitch, and A Cerami. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-554, 1985.
25. Beutler, B., and V. Kruys. Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. J. Cardiovasc. Pharmacol. 25: S1-S8, 1995.
26. Beutler, B., J. Mahoney, N. L. Trang, P. Pekala, and A. Cerrami. Purification of cachectin, a lipoprotein lipasesuppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp. Med. 161:984-995, 1985.
27. Beutler, B., I. W. Milsark, and A. C. Cerami. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229: 869-871, 1985.
28. Biasucci, L. M., A. Vitelli, G. Liuzzo, S. Altamura, G. Caligiuri, C. Monaco, A. G. Rebuzzi, G. Ciliberto, and A. Maseri. Elevated levels of interleukin 6 in unstable angina. Circulation 94:874-877, 1996.
29. Biffl, W. L., E. E. Moore, F. A. Moore, and C. C. Silliman. Nitric oxide reduces endothelial expression of intracellular adhesion molecule-1. J. Surg. Res. 63:328-332, 1996.
30. Bogoyevitch, M. A., J. Gillespie-Brown, A. J. Ketterman, S. J. Fuller, R. Ben-Levy, A. Ash worth, C. J. Marshall, and P. H. Sugden. Stimulation of the stress-activated mitogen activated protein kinase subfamilies in perfused heart: p38/RK mitogen activated protein kinases and c-Jun N-Terminal kinases are activated by ischemia/reperfusion. Circ. Res. 79: 162-173, 1996.
31. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. A novel protein that interacts with the death domain of Fas/APOl contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798, 1995.
32. Boyle, E. M., E. D. Verrier, and B. D. Spiess. Endothelial cell injury in cardiovascular surgery. Ann. Thorac. Surg. 62: 1549-1557, 1996.
33. Brady, A. J. B., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1963-H1966, 1992.
34. Brady, A. J. B., J. B. Warren, P. A. Poole-Wilson, T. J. Williams, and S. E. Harding. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H176-H182, 1993.
35. Brew, E. B., M. B. Mitchell, T. F. Rehring, F. GamboniRobertson, R. C. Mcintyre, A. H. Harken, and A. Banerjee. The role of bradykinin in cardiac functional protection after global ischemia-reperfusion in the rat heart. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1370-H1378, 1995.
36. Brown, J. M., B. O. Anderson, J. Repine, P. Shanley, C. White, M. A. Grosso, A. Banerjee, D. Bensard, and A. H. Harken. Neutrophils contribute to TNF induced myocardial tolerance to ischemia. J. Mol. Cell. Cardiol. 24: 485-495, 1992.
37. Brown, J. M., G. J. Buehler, E. M. Berger, M. A. Grosso, G. J. Whitman, L. S. Terada, J. Leff, A. H. Harken, and J. E. Repine. Albumin decreases hydrogen peroxide and reperfusion injury in isolated rat hearts. Inflammation 13: 583-589, 1989.
38. Brown, J. M., M. A. Grosso, L. S. Terada, A. Banerjee, and A. H. Harken. Endotoxin induces in vivo myocyte HSP-70 expression and protection from cardiac ischemic injury (Abstract). J. Cell. Biochem. 195:17D, 1993.
39. Brown, J. M., M. A. Grosso, L. S. Terada, C. J. Beehler, K. M. Toth, G. J. Whitman, and A. H. Harken. Erythrocytes decrease myocardial hydrogen peroxide levels and reperfusion injury. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H584H588, 1989.
40. Brown, J. M., M. A. Grosso, L. S. Terada, G. J. Whitman, A. Banerjee, C. W. White, A. H. Harken, and J. E. Repine. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci. USA 86: 2516-2520, 1989.
41. Brown, J. M., A. H. Harken, and J. B. Sharefkin. Recombinant DNAand surgery. Ann. Surg. 212:178-186, 1990.
42. Brown, J. M., L. S. Terada, M. A. Grosso, G. J. Whitman, S. E. Velasco, A. Patt, A. H. Harken, and J. E. Repine. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic isolated rat hearts. J. Clin. Invest. 81:1297-1301, 1988.
43. Brown, J. M., C. W. White, L. S. Terada, M. A. Grosso, P. F. Shanley, D. W. Mulvin, A. Banerjee, G. J. Whitman, A. H. Harken, and J. E. Repine. Interleukin-1 pretreatment decreases ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 87:5026-5030, 1990.
44. Buchman, T. G. Manipulation of stress gene expression: a novel therapy for the treatment of sepsis? Crit. Care Med. 22: 901-903, 1994.
45. Buerke, M., T. Murohara, C. Skurk, C. Nuss, A. M. Tomaselli, and A. M. Lefer. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc. Natl. Acad. Sci. USA 92:8031-8035, 1995.
46. Bullough, D. A., M. J. Magill, G. S. Firestein, and K. M. Mullane. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated myocytes. J. Immunol. 155: 2579-2586, 1995.
47. Buscher, D., R. A. Hipskind, S. Krautwald, T. Reimann, and M. Baccarini. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell. Biol. 15:466-475, 1995.
48. Butt, T. R., and S. K. Karathasis. Transcription factors as drug targets: opportunities for therapeutic selectivity. Gene Expr. 4:319-336, 1995.
49. Cain, B. S., D. R. Meldrum, A. H. Harken, and R. C. Mclntyre. Physiologic basis for anti-cytokine clinical trials. J. Am. Coll. Surg. In press.
50. Cain, B. S., D. R. Meldrum, C. H. Selzman, J. C. Cleveland, X. Meng, B. C. Sheridan, A. Banerjee, and A. H. Harken. Surgical implications of vascular endothelial physiology. Surgery 122: 516-526, 1997.
51. Calvin, J. E., A. A. Driedger, and W. J. Sibbald. An assessment of myocardial function in human sepsis utilizing EGG gated cardiac scintigraphy. Chest 38: 579-586, 1981.
52. Cameron, D. Initiation of white cell activation during cardiopulmonary bypass: cytokines and receptors. J. Cardiovasc. Pharmacol. 27: S1-S5, 1996.
53. Carson, D. A., and J. M. Ribeiro. Apoptosis and disease. Lancet 341:1251-1254, 1993.
54. Cerretti, D. P., C. J. Klotsky, B. Mosley, N. Nelson, K. VanNess, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, and R. A. Black. Molecular cloning of the IL-l converting enzyme. Science 256: 97-100, 1992.
55. Chaudry, I. H., A. Ayala, W. Ertel, and R. N. Stephan. Hemorrhage and resuscitation: immunological aspects. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R663R678, 1990.
56. Chen, F., D. C. Kühn, S. C. Sun, L. J. Gaydos, and L. M. Demers. Dependence and reversal of nitric oxide production on NFi
57. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512, 1995.
58. Cleveland, J. C., D. R. Meldrum, B. S. Cain, A. Banerjee, and A. H. Harken. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation 96:29-32, 1997.
59. Cleveland, J. C., D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken. Optimal myocardial preservation: cooling, cardioplegia and conditioning. Ann. Thorac. Surg. 61: 760-768, 1996.
60. Cleveland, J. C., D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken. Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive potassium channel. J. Mol. Cell. Cardiol. 29:175-182, 1997.
61. Cleveland, J. C., D. R. Meldrum, R. T. Rowland, A. Banerjee, and A. H. Harken. Preconditioning and hypothermic cardioplegia protect human- heart equally against ischemia. Ann. Thorac. Surg. 63:147-152, 1997.
62. Cleveland, J. C., D. R. Meldrum, R. T. Rowland, B. S. Cain, X. Meng, F. Gamboni-Robertson, A. Banerjee, and A. H. Harken. Ischemic preconditioning of human myocardium: protein kinase C mediates a permissive role for ai-adrenoceptors. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H902-H908, 1997.
63. Cleveland, J. C., D. R. Meldrum, R. T. Rowland, B. C. Sheridan, A. Banerjee, and A. H. Harken. The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery 120:345-353, 1996.
64. Cleveland, J. C., M. Wolmering, D. R. Meldrum, R. T. Rowland, T. F. Rehring, B. C. Sheridan, A. H. Harken, and A. Banerjee. Ischemic preconditioning in human and rat ventricle. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1786H1794, 1996.
65. Cleveland, J. L., and J. N. Ihle. Contenders in FasL/TNF death signaling. Cell 81:479-482, 1995.
66. Clowes, G. H. A., B. C. George, C. A. Villee, and C. A. Saravis. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N. Engl. J. Med. 308: 545-588, 1983.
67. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin 1. FEBS Lett. 364: 229-233, 1995.
68. Gumming, D. V. E., R. J. Heads, A. Watson, D. S. Latchman, and D. M. Yellon. Differential protection of primary rat cardiomyocytes by transfection of specific heat stress proteins. J. Mol. Cell. Cardiol. 28:2343-2349, 1996.
69. DeCaterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, W. S. Shin, and J. K. Liao. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68, 1995.
70. Denlinger, L. C., P. L. Fisette, K. A. Garis, G. Kwon, A. Vasquez-Torres, A. D. Simon, B. Nguyen, R. A. Proctor, P. J. Bertics, and J. A. Corbett. Regulation of inducible nitric oxide synthase expression by macrophage purinoceptors and calcium. J. Biol. Chem. 271:337-342, 1996.
71. Derijart, B., J. Raingeaud, T. Barret, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685, 1995.
72. Dettbarn, C. A., R. Betto, G. Salviati, P. Palade, G. M. Jenkins, and R. A. Sabbadini. Modulation of cardiac sarcoplasmic reticulum ryanodine receptor by sphingosine. J. Mol. Cell. Cardiol. 26:229-242, 1994.
73. Dinarello, C. A. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:153-205, 1989.
74. 73.' Dinarello, C. A. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991.
75. Dinarello, C. A. Role of interleukin-1 in infectious disease. Immunol. Rev. 127:119-146, 1992.
76. Dinarello, C. A. Biologic basis for interleukin 1 in disease. Blood 87:2095-2147, 1996.
77. Dinarello, C. A., and C. A. Cannon. Cytokine measurements in septic shock. Ann. Intern. Med. 119:853-854, 1993.
78. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, and J. V. O'Connor. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of IL-1. J. Exp. Med. 163: 1433-1450, 1986.
79. Dinarello, C. A., R. A. Dempsey, M. Allegretta, D. R. Parkinson, and J. W. Mier. Inhibitory effects of elevated temperature on human monokine production and natural killer cell activity. Cancer Res. 46: 6236-6241, 1986.
80. Dinarello, C. A., J. A. Gelfand, and S. M. Wolff. Anticytokine strategies in the treatment of the sytemic inflammatory response syndrome. JAMA 269:1829-1835, 1993.
81. Dinarello, C. A-, and N. H. Margolis. Stopping the cuts: the recently discovered enzymes that process the precursors of inflammatory cytokines arc good targets for the design of new anti-inflammatory therapeutic agents. Curr. Biol. 5: 587-590, 1995.
82. Donnelly, T., R. Sievers, F. Vissern, W. Welch, and C. Wolfe. Heat shock protein induction in rat hearts. A role for improved myocardial salvage after ischemia and reperfusion? Circulation 85:769-778, 1992.
83. Downey, J. M., M. V. Cohen, K. Ytrehus, and Y. Liu. Cellular mechanisms in ischemic preconditioning: the role of endogenous adenosine and PKC. Ann. NY Acad. Sci. 723: 82-98, 1994.
84. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. Requirement of endogenous tumor necrosis factor/ cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766, 1990.
85. Ellrodt, A. G., M. S. Riedinger, A. Kimchi, D. S. Herman, J. Maddahi, H. J. C. Swan, and G. H. Murata. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am. Heart J. 110:402-409, 1985.
86. Ertel, W., J. P. Kremer, J. Kenney, U. Steckholzer, D. Jarrar, O. Trentz, and F. W. Schildberg. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995.
87. Ertel, W., D. R. Meldrum, M. H. Morrison, A. Ayala, and I. H. Chaudry. Immunoprotective effect of a calcium channel blocker on macrophage antigen presentation function, la expression, and IL-1 synthesis following hemorrhage. Surgery 108: 154-160, 1990.
88. Ertel, W., M. H. Morrison, D. R. Meldrum, A. Ayala, and I. H. Chaudry. Ibuprofen restores cellular immunity and decreases susceptibilty to sepsis following hemorrhage. J. Surg. Res. 53: 55-61, 1992.
89. Ertel, W., F. A. Scholl, H. Gallati, M. Bonaccio, and F. W. Schildberg. Increased release of soluble tumor necrosis factor receptors into the blood during clinical sepsis. Arch. Surg. 129: 1330-1337, 1994.
90. Evans, T. J., D. Moyes, A. Carpenter, R. Martin, H. Loetscher, W. Lesslauer, arid J. Cohen. Protective effect of 55- but not 75-kDa soluble tumor necrosis factor receptorimmunoglobin G fusion proteins in an animal model of gramnegative sepsis. J. Exp. Med. 180: 2173-2179, 1994.
91. Exley, A. R., W. Buurman, M. Bodmer, and J. Bohen. Monoclonal antibody (Mab) to recombinant human tumor necrosis factor (rhTNF) in the prophylaxis and treatment of endotoxic shock in Cynomogus monkeys (Abstract). Clin. Sci. (Colch.) 76:50, 1989.
92. Feinstein, D. L., E. Galea, D. A. Aquino, G. C. Li, H. Xu, and D. J. Reis. Heat shock protein 70 suppresses astroglialinducible nitric oxide synthase expression by decreasing NFi
93. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992.
94. Finkel, T. H., M. J. Pabst, H. Suzuki, L. A. Guthrie, J. R. Forehand, W. A. Phillips, and R. B. Johnston. Priming of neutrophils and macrophage for the enhanced release of superoxide anion by the calcium ionophore ionomycin: implications for regulation of the respiratory burst. J. Biol. Chem. 262: 12589-12596, 1987.
95. Fisher, C. J. J., J. M. Agosti, S. M. Opal, S. F. Lowry, R. A. Balk, J. C. Sadoff, E. Abraham, R. M. H. Schein, and E. Benjamin. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N. Engl. J. Med. 334: 1697-1702, 1996.
96. Fisher, S. C. J., S. M. Opal, J. F. Dhainaut, S. Stephens, J. L. Zimmerman, P. Nightingale, S. J. Harris, R. M. H. Schein, E. A. Panacek, J. L. Vincent, G. E. Foulke, E. L. Warren, C. Garrard, G. Park, M. W. Bodmer, J. Cohen, C. V. Linden, A. S. Cross, and J. C. Sadoff. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med. 21: 318-327, 1993.
97. Fouqueray, B., C. Philippe, A. Amrani, J. Ferez, and L. Baud. Heat shock prevents LPS-induced TNF-a synthesis by rat mononuclear phagocytes. Eur. J. Immunol. 22: 2983-2987, 1992.
98. Fralix, T. A., E. Murphy, R. E. London, and C. Steenbergen. Protective effects of adenosine in the reperfused rat heart: changes in metabolism and intracellular ion homeostasis. Am. J. Physiol. 264 (Cell Physiol. 33): C986-C994, 1993.
99. Friese, R. S., D. A. Fullerton, R. C. Mclntyre, T. F. Rehring, J. A. Agrafojo, A. Banerjee, and A. H. Harken. Nitric oxide prevents neutrophil-mediated pulmonary vasomotor dysfunction in acute lung injury. J. Surg. Res. 63: 23-28, 1996.
100. Friese, R. S., T. F. Rehring, M. Wollmering, E. E. Moore, L. L. Ketch, A. Banerjee, and A. H. Harken. Trauma primes cells. Shock 1:388-394, 1994.
101. Fullerton, D. A., R. C. Mclntyre, A. R. Hahn, J. Agrafojo, K. Koike, A. Banerjee, and A. H. Harken. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L1029-L1035, 1995.
102. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. Processing of tumor necrosis factor-a precursor by metalloproteinases. Nature 370:555-557, 1994.
103. Geppert, T. D., C. E. Whitehurst, P. Thompson, and B. Beutler. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis in the rat through the Ras/Raf-1/MEK/ MAPK pathway. Mol. Med. 1:93-103, 1994.
104. Gershenwald, J. E., Y. M. Fong, and T. J. I. Fahey. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 87:4966-4970, 1990.
105. Giroir, B. P., J. H. Johnson, T. Brown, G. L. Alien, and B. Beutler. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90:693-698, 1992.
106. Giroir, P. B., J. W. Horton, J. White, K. L. Mclntyre, and C. Q. Lin. Inhibition of tumor necrosis factor prevents myocardial depression during burn shock. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H118-H124, 1994.
107. Glauser, F. L., G. G. DeBlois, D. E. Bechard, R. E. Merchant, A. J. Grant, A. A. Fowler, and R. P. Fairman. Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep. J. Appl. Physiol. 64:1030-1037, 1988.
108. Goldhaber, J. L., K. H. Kim, P. D. Natterson, T. Lawrence, P. Yang, and J. N. Weiss. Effects on TNF-a on [Ca2+]j and contractility in isolated adult rabbit ventricular myocytes. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1449-H1455, 1996.
109. Goto, M., Y. Liu, X. M. Yang, J. L. Ardell, M. V. Cohen, and J. M. Downey. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77: 611-621, 1995.
110. Gottlieb, R. A., K. O. Burleson, R. A. Kloner, B. M. Babior, and R. L. Engler. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94:1621-1628, 1994.
111. Gross, G. J., and J. Auchampach. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70:223-233, 1992.
112. Gulick, T., M. K. Chung, S. J. Pieper, L. G. Lange, and G. F. Schreiner. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte adrenergic responsiveness. Proc. Natl. Acad. Sci. USA 86: 6753-6757, 1989.
113. Gurevitch, J., I. Frolkis, Y. Yuhas, Y. Paz, M. Matsa, R. Mohr, and V. Yakirevich. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J. Am. Coll. Cardiol. 28:247-252, 1996.
114. Guyton, K. Z., Y. Liu, M. Gorospe, Q. Xu, and N. J. Holbrook. Activation of mitogen-activated protein kinase by H2Ü2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:4138-4142, 1996.
115. Hall, T. J. Role of hsp70 in cytokine production. Experientia 50: 1048-1053, 1994.
116. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811, 1994.
117. Hau, J., J. D. Lee, P. S. Tobias, and R. J. Ulevitch. Endotoxin induces rapid tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268:25009-25014, 1993.
118. Han, J., B. Richter, Z. Li, V. Kravchenko, and R. J. Ulevitch. Molecular cloning of the p38 MAP kinase. Biochim. Biophys.Acta 16: 224-227, 1995.
119. Hannun, Y. A. Functions of ceramide in coordinating the metabolic response to stress. Science 274:1855-1859, 1996.
120. Hattler, B. G., A. Zeevi, C. V. Oddis, and M. S. Finkel. Cytokine induction during cardiac surgery: analysis of TNFalpha expression pre- and postcardiopulmonary bypass. J. Card. Surg. 10:418-422, 1995.
121. Haziot, A., G. W. Rong, X. Y. Lin, J. Silver, and S. M. Goyert. Recombinant soluble CD 14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154: 6529-6532, 1995.
122. Headrick, J. P. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J. Mol. Cell. Cardiol. 28:1227-1240, 1996.
123. Herskovitz, A., S. Choi, A. A. Ansari, and S. Wesselingh. Cytokine mRNA expression in the postischemic/reperfused myocardium. Am. J. Pathol. 146:419-428, 1995.
124. Heumann, D., D. L. Roy, G. Zanetti, H. P. Eugster, B. Ryffel, M. Hahne, J. Tschopp, and M. P. Glauser. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis. J. Inflamm. 47: 173-179, 1995.
125. Hill, G. E., D. R. Springall, and R. A. Robbins. Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass. Surgery 121:449-455, 1997.
126. Hirota, H., K. Yoshida, T. Taga, and T. Kishimoto. gplSO Signaling pathways: recent advances and implications for cardiovascular disease. Trends Cardiovasc. Med. 6:109-115, 1996.
127. Horton, J. W. Cellular basis for burn-mediated cardiac dysfunction in adult rabbits. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2615-H2621, 1996.
128. Howe, L. R., S. J. Leevers, N. Gomez, S. Nakielny, P. Cohen, and C. J. Marshall. Activation of the MAP kinase pathway by the protein kinase raf. Cell 71:335-342, 1992.
129. Hsu, H., J. Xiong, and D. V. Goeddel. The TNF receptor 1-associated protein TRADD signals cell death and NFtcB activation. Cell 81:495-504, 1995.
130. Huot, J., F. Houle, F. Marceau, and J. Landry. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock pathway in vascular endothelial cells. Circ. Res. 80:383-392, 1997.
131. Hutter, M. M., R. E. Sievers, V. Barbosa, and C. L. Wolfe. Heat shock protein induction in rat hearts. A direct correlation between the amount of heat shock protein induced and the degree of myocardial protection. Circulation 89:355-362, 1994.
132. Ishiyama, S., M. Hiroe, T. Nishikawa, S. Abe, T. Shimojo, H. Ito, S. Ozasa, K. Yamakawa, M. Matsuzaki, M. U. Mohammed, H. Nakazawa, T. Kasajima, and F. Marumo. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis. Circulation 95: 489-496, 1997.
133. Itoh, G., T. Jie, J. Tamura, M. Suzuki, Y. Suzuki, M. Ikeda, M. Koike, and M. Nomura. Apoptosis and human myocardial ischemic damage, including conduction system. Basic Appl. Myol. 6: 237-240, 1996.
134. Itoh, G., J. Tamura, M. Suzuki, Y. Suzuki, M. Ikeda, M. Koike, T. Jie, M. Nomura, and K. Ito. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method of and DNA agarose electrophoresis. Am. J. Pathol. 146:1235-1331, 1996.
135. James, T. N. Normal and abnormal consequences of apoptosis in the human heart from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90:556-573, 1994.
136. Jha, P., H. Jacobs, D. Bose, R. Wang, J. Yang, R. B. Light, and S. Mink. Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in the dog ventricle. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1402-H1410, 1993
137. Kajstura, J., W. Cheng, K. Reiss, W. A. Clark, E. H. Sonnenblick, S. Krajewski, J. C. Reed, G. Olivetti, and P. Anversa. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74:86-107, 1996.
138. Kapadia, S., J. Lee, G. Torre-Amione, H. H. Birdsall, T. S. Ma, and D. L. Mann. Tumor necrosis factor-a gene and protein expression in adult feline myocardium after endotoxin administration. J. Clin. Invest. 96:1042-1052, 1995.
139. Kawai, M., R. Nishikomori, E. Y. Jung, G. Tai, C. Yamanaka, M. Mayumi, and T. Heike. Pyrrolidine dithiocarbamate inhibits intracellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J. Immunol. 154: 2333-2341, 1995.
140. Keaney, J. F., J. M. Hare, J. L. Balligand, J. Loscalzo, T. W. Smith, and W. S. Colucci. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2646-H2652, 1996.
141. Keller, R. S., J. J. Jones, K. F. Kim, P. R. Myers, H. R. Adams, J. L. Parker, and L. Rubin. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide? Shock 4: 338-344, 1995.
142. Kelly, R. A., and T. W. Smith. Cytokines and cardiac contractile function. Circulation 95: 778-781, 1997.
143. Kishimoto, T., S. Akira, and T. Taga. Interleukin-6 and its receptor: a paradigm for cytokines. Science 258:593-597, 1992.
144. Kitakaze, M., M. Hori, and T. Kamada. Role of adenosine and its interaction with alpha-adrenoceptor activity in ischemic and reperfusion injury of the myocardium. Cardiovasc. Res. 27: 18-27, 1993.
145. Kitakaze, M., K. Node, K. Komamura, T. Minamino, M. Inoue, M. Hori, and T. Kaniada. Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia. J. Mol. Cell. Cardiol. 27:2149-2154, 1995.
146. Kitakaze, M., K. Node, T. Minamino, K. Komamura, H. Funaya, Y. Shinozaki, M. Chujo, H. Mori, M. Inoue, M. Hori, and T. Kamada. Role of activation of protein kinase C in the infarct size limiting effect of ischemic preconditioning through the activation of 5′-nucleotidase. Circulation 93: 781-791, 1996.
147. Klabunde, R. E., and A. F. Coston. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxin shock. Shock 3: 73-78, 1995.
148. Kloner, R. A., and T. Shook. Previous angina alters inhospital outcome in TIMI-4: a clinical correlate to preconditioning. Circulation 91:37-45, 1995.
149. Kolesnick, R. N. Sphingosine and derivatives as cellular signals. Prog. LipidRes. 30:1-38, 1991.
150. Krown, K. A., M. T. Page, C. Nguyen, D. Zechner, V. Gutierrez, K. L. Comstock, C. G. Glembotski, P. J. E. Quintana, and R. A. Sabbadini. Tumor necrosis factor alphainduced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. -Invest. 98:2854-2865, 1996.
151. Krown, K. A., Y. Yasui, M. Brooker, A. Dubin, C. Nguyen, G. Harris, P. McDonough, C. G. Glembotski, P. Palade, and R. A. Sabbadini. TNF-a receptor expression in rat cardiac myocytes: TNF inhibition of L-type Ca2 current and Ca2+ transients. FEES Lett. 376:24-30, 1995.
152. Kumar, A., V. Thota, L. Dee, J. Olson, E. Uretz, and J. E. Parrillo. Tumor necrosis factor-alpha and interleukin 1-beta are responsible for the in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 183: 949-958, 1996.
153. Lasley, R. D., J. W. Rhee, D. G. L. V. Wylen, and J. R. M. Mentzer. Adenosine AI receptor mediated protection of the globally ischemic isolated rat heart. J. Mol. Cell. Cardiol. 22: 39-47, 1990.
154. Last-Barney, K., C. A. Homon, R. B. Faanes, and V. J. Merluzzi. Synergistic and overlapping activities of tumor necrosis factor-a and IL-1. J.
155. Latini, R., M. Bianchi, E. Correale, C. A. Dinarello, G. Fantuzzi, C. Fresco, A. P. Maggoini, M. Mengozzi, S. Romano, and L. Shapiro. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin 1 receptor antagonist. J. Cardiovasc. Pharmacol. 23:1-6, 1994.
156. Lee, J. C., J. T. Laydon, P. C. McDonnel, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Keys, S. W. Landvatter, J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
157. Lee, J. C., and P. R. Young. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukoc. Biol. 59:152-157, 1996.
158. Lee, J. D., V. Kravchenko, T. N. Kirkland, J. Han, N. Mackman, A. Moriarty, D. Letureq, P. S. Tobias, and R. J. Ulevitch. GPI-anchored or integral membrane forms of CD 14 mediate identical cellular responses to endotoxin. Proc. Natl. Acad. Sci. USA 90:9930-9934, 1993.
159. Lefer, A. M. Origin of myocardial depressant factor in shock. Am. J. Physiol. 218:1423-1427, 1970.
160. Lefer, A. M. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Federation Proc. 29: 1836-1847, 1970.
161. LeTulzo, Y., R. Shenkar, D. Kaneko, P. Moine, G. Fantuzzi, C. A. Dinarello, and E. Abraham. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor kappa B regulation and cytokine expression. J. Clin. Invest. 99:1516-1524, 1997.
162. Levine, B., J. Kaiman, L. Mayer, H. Fillit, and M. Packer. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323: 236-241, 1990.
163. Levitzki, A. Signal transduction interception as a novel approach to disease management. Ann. NY Acad. Sci. 766; 363-368, 1995.
164. Levitzki, A., and A. Gazit. Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788, 1995.
165. Li, G. C., and Z. Werb. Correlation between the synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc. Natl. Acad. Sci. USA 79: - 3218-3226, 1982.
166. Li, S., and J. M. Sedivy. Raf-1 protein kinase activates the NFi
167. Liu, S. L., S. D. Esposti, T. Yao, A. M. Diehl, and M. A. Zern. Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 22:1474-1481, 1995.
168. Lyons, C. R. The role of nitric oxide in inflammation. Adv. Immunol. 60:323-371, 1995.
169. Mallat, Z., A. Tedgui, F. Fontaliran, R. Frank, M. Durigon, and G. Fontaine. Evidence of apoptosis in arrythmogenic right ventricular dysplasia. N. Engl. J. Med. 335:1190-1196, 1996.
170. Mallinin, N. L., M. P. Boldin, A. V. Kovalenko, and D. Wallach. MAP3K-related kinase involved in NFi
171. Marber, M., D. Latchman, J. Walker, and D. Yellon. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-1272, 1993.
172. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098, 1997.
173. Massey, K. D., R. M. Stricter, S. L. Kunkel, J. M. Danforth, and T. J. Standiford. Cardiac myocytes release leukocytestimulating factors. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H980-H987, 1995.
174. Matsumori, A., K. Ono, R. Nishio, H. Igata, T. Shioi, S. Matsui, Y. Furukawa, A. Iwasaki, Y. Nose, and S. Sasayama. Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside oubain. Circulation 96:1501-1506, 1997.
175. Matsumori, A., K. Ono, R. Nishio, Y. Nose, and S. Sasayama. Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: a possible mechanism for its effect in heart failure. Circulation 96:1386-1389, 1997.
176. Matsumori, A., K. Ono, Y. Sato, T. Shioi, Y. Nose, and S. Sasayama. Differential modulation of cytokine production by drugs: implications for therapy in heart failure. J. Mol. Cell. Cardiol. 28:2491-2499, 1996.
177. Maulik, N., M. Watanabe, D. Engelman, R. M. Engelman, V. E. Kagan, E. Kisin, V. Tyurin, G. A. Cordis, and D. K. Das. Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am. J. Physiol. 269 (Cell Physiol. 38): C907-C916, 1995.
178. McGeehan, G. M., J. D. Becherer, R. Bast, C. M. Boyer, B. Champion, K. M. Connolly, J. G. Conway, P. Furdon, S. Karp, S. Kidao, A. B. McEIroy, J. Nichols, K. M. Pryzwansky, F. Schoenen, L. Sekut, A. Truesdale, M. Verghese, J. Warner, and J. P. Ways. Regulation of TNF-alpha processing by a metalloproteinase inhibitor. Nature 370:558-561, 1994.
179. Meldrum, D. R. Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning. J. Surg. Res. In press.
180. Meldrum, D. R., A. Ayala, and I. H. Chaudry. Energetics of defective macrophage antigen presentation following hemorrhage. Surgery 112:150-158, 1992.
181. Meldrmn, D. R., A. Ayala, and I. H. Chaudry. Mechanism of diltiazem's immunomodulatory effects following hemorrhage and resuscitation. Am. J. Physiol. 265 (Cell Physiol. 34): C412C421, 1993.
182. Meldrum, D. R., A. Ayala, P. Wang, W. Ertel, and I. H. Chaudry. Association between decreased splenic ATP levels and immunodepression. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R351-R357, 1991.
183. Meldrum, D. R., B. S. Cain, J. C. Cleveland, X. Meng, A. Ayala, A. Banerjee, and A- H. Harken. Adenosine decreases post-ischemic myocardial TNF-ot production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92:472-477, 1997.
184. Meldrum, D. R., J. C. Cleveland, X. Meng, B. C. Sheridan, A. Banerjee, and A. H. Harken. Hemorrhage induces acute cardioadaptation to ischemia reperfusion by an oti-adrenoceptormediated, protein synthesis-independent mechanism. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R718R725, 1997.
185. Meldrum, D. R., J. C. Cleveland, M. B. Mitchell, R. T. Rowland, A. Banerjee, and A. H. Harken. Constructive priming of myocardium against ischemia-reperfusion injury. Shock 6:238-242, 1996.
186. Meldrum, D. R., J. C. Cleveland, M. B. Mitchell, B. C. Sheridan, F. Robertson, A. H. Harken, and A. Banerjee. Protein kinase C mediates Ca2+ induced cardioadaptation to ischemia-reperfusion injury. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R1718-R1726, 1996.
187. Meldrum, D. R., J. C. Cleveland, E. E. Moore, D. A. Partrick, A. Banerjee, and A. H. Harken. Adaptive and maladaptive mechanisms of cellular priming. Ann. Surg. 226: 587-598, 1997.
188. Meldrum, D. R., J. C. Cleveland, R. T. Rowland, A. Banerjee, and A. H. Harken. Calcium induced inotropy is in part mediated by protein kinase C. J. Surg. Res. 63: 400-405, 1996.
189. Meldrum, D. R., J. C. Cleveland, R. T. Rowland, A. Banerjee, A. H. Harken, and X. Meng. Early and delayed preconditioning: differential mechanisms and additive protection. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H725-H733, 1997.
190. Meldrum, D. R., J. C. Cleveland, B. C. Sheridan, X. Meng, F. Robertson, B. S. Cain, A- H. Harken, and A. Banerjee. Protein kinase C isoform diversity in preconditioning. J. Surg. Res. 69:183-187, 1997.
191. Meldrum, D. R., J. C. Cleveland, B. C. Sheridan, R. T. Rowland, A. Banerjee, and A. H. Harken. Cardiac preconditioning with calcium: clinically accessible myocardial protection. J. Thorac. Cardiovasc. Surg. 112: 778-786, 1996.
192. Meldrum, D. R., J. C. Cleveland, B. C. Sheridan, R. T. Rowland, A. Banerjee, and A. H. Harken. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann. Thorac. Surg. 61:1273-1280, 1996.
193. Meidruin, D. R., J. C. Cleveland, B. C. Sheridan, R. T. Rowland, A. Banerjee, and A. H. Harken. Differential effects of adenosine preconditioning on the post-ischemic rat myocardium. J. Surg. Res. 65:156-164, 1996.
194. Meldrum, D. R., J. C. Cleveland, B. C. Sheridan, R. T. Rowland, C. H. Selzman, A. Banerjee, and A. H. Harken. Alpha-adrenergic activation of myocardial NFB during hemorrhage. J. Surg. Res. 69:268-276, 1997.
195. Meldrum, D. R., C. A. Dinarello, J. C. Cleveland, L. Shapiro, B. C. Sheridan, and A. H. Harken. P38 MAP kinase-mediated myocardial TNF-ot production contributes to post-ischemic cardiac dysfunction (Abstract). Circulation 96: 1-556, 1997.
196. Meldrum, D. R., M. B. Mitchell, A. Banerjee, and A. H. Harken. Cardiac preconditioning: induction of endogenous tolerance to ischemia-reperfusion injury. Arch. Surg. 128:1208-1211, 1993.
197. Meldrum, D. R., R. Shenkar, B. C. Sheridan, B. S. Cain, E. Abraham, and A. H. Harken. Hemorrhage activates myocardial NFi
198. Meldrum, D. R., B. C. Sheridan, J. C. Cleveland, D. A. Fullerton, A. Banerjee, and A. H. Harken. Neutrophils are required for endotoxin induced myocardial cross-tolerance to ischemia-reperfusion injury. Arch, Surg. 131:1203-1208, 1996.
199. Meng, X., L. Ao, J. M. Brown, D. A. Fullerton, A. Banerjee, and A. H. Harken. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 7:111-118, 1997.
200. Meng, X., J. M. Brown, L. Ao, A. Banerjee, and A. H. Harken. Norepinephrine induces cardiac heat shock protein and delayed cardioprotection in the rat through ai-adrenoceptors. Cardiovasc. Res. 32:374-383, 1996.
201. Meng, X., J. M. Brown, L. Ao, W. Franklin, A. Banerjee, and A. H. Harken. Heat shock protein 70 contributes to the induced cardiac resistance to bacterial lipopolysaccharide in the rat. Am. J. Physiol. 271 (Cell Physiol. 40): C1316-C1324, 1996.
202. Mihm, S., D. Gaiter, and W. Droge. Modulation of transcription factor NFκB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J. 9: 246-252, 1995.
203. Mitchell, M. B., X. Meng, C. G. Parker, A. H. Harken, and A. Banerjee. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73-81, 1995.
204. Mohler, K. M., P. R. Sleath, J. N. Fitzner, D. P. Cerretti, M. Alderson, S. S. Kerwar, D. S. Tolerance, C. Otten-Evans, T. Greenstreet, and K. Weerawarna. Protection against a lethal dose of endotoxin by an inhibitor of TNF processing. Nature 370:218-220, 1994.
205. Mohler, K. M., D. S. Torrance, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548-1561, 1993.
206. Moodie, S. A., B. M. Willumsen, M. J. Weber, and A. Wolfman. Complexes of Ras.GTP with Raf-1 and mitogen activated protein kinase kinase. Science 260:1658-1661, 1993.
207. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399, 1995.
208. Muller, J. M., H. W. Ziegler-Heitbrock, and P.A. Baeuerle. Nuclear factor kappa B, a mediator of LPS effects. Immunobiology 187:233-256, 1993.
209. Murray, D. R., and G. L. Freeman. Tumor necrosis factoralpha induces a biphasic effect on myocardial contractility in conscous dogs. Circ. Res. 78:154-160, 1995.
210. Murry, C., R. Jennings, and K. Reimer. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986.
211. Nakanishi, K., J. Vinten-Johansen, D. J. Lefer, Z. Zhao, W. C. Fowler, D. S. McGee, and W. E. Johnston. Intracoronary L-arginine during reperfusion improves endothelial func-tion and reduces infarct size. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1650-H1658, 1992.
212. Nakano, M., A. A. Knowlton, T. Yokoyama, W. Lesslauer, and D. L. Mann. Tumor necrosis factor-a-induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1231-H1239, 1996.
213. Nakano, M., D. L. Mann, and A. A. Knowlton. Blocking the endogenous increase in HSP72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiomyocytes. Circulation 95:1523-1531, 1997.
214. Narula, J., N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B. A. Khaw. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335:1182-1189, 1996.
215. Natanson, C., W. D. Huffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Dranner. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120: 771-783, 1994.
216. Nelson, D. W., J. M. Brown, A. Banerjee, D. D. Bensard, K. B. Rogers, C. R. Locke-Winter, B. O. Andersen, and A. H. Harken. Pretreatment with a nontoxic derivative of endotoxin (MPL) induces functional protection against cardiac ischemia reperfusion injury. Surgery 110:365-369, 1991.
217. Neumann, F. J., I. Ott, M. Gawaz, G. Richardt, H. Holzapfel, M. Jochum, and A. Schomig. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92: 748-755, 1995.
218. Nishizuka, Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-613, 1992.
219. Nussler, A. K., and T. R. Billiar. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 54: 171-178, 1993.
220. Obeid, L. M., C. M. Linardie, L. A. Karolak, and Y. A. Hannun. Programmed cell death induced by ceramide. Science 259:1769-1771, 1993.
221. Ohta, H., Y. Yatomi, E. A. Sweeney, S. I. Hakomori, and Y. Igarashi. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-a in human neutrophils. FEBS Lett. 355:267-270, 1994.
222. Okusawa, S., J. A. Gelfand, T. Ikejima, R. J. Conolly, and C. A. Dinarello. Interleukin 1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81: 1162-1172, 1988.
223. Olivetti, G., R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J.A. Nitahara, E. Quaini, C. DiLoreto, C. A. Beltrami, S. Krajewski, J. C. Reed, and P. Anversa. Apoptosis in the failing human heart. N. Engl. J. Med. 336:1131-1141, 1997.
224. Oral, H., G. W. Dorn, and D. L. Mann. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-a in the adult mammalian cardiac myocyte. J. Biol. Chem. 272:4836-4842, 1997.
225. Oral, H., S. Kapadia, M. Nakano, G. Torre-Amione, J. Lee, D. Lee-Jackson, J. B. Young, and D. L. Mann. Tumor necrosis factor-a and the failing human heart. Clin. Cardiol. 18: S20-S27, 1995.
226. Ottani, F., M. Galvani, D. Ferrini, F. Sorbello, P. Limonctti, D. Pantoli, and F. Rusticall. Prodromal angina limits infarct size. Circulation 91:291-297, 1995.
227. Packer, M. Is tumor necrosis factor an important neurohormoral mechanism in chronic heart failure? Circulation 92: 1379-1382, 1995.
228. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. The receptor for the cytotoxic ligand TRAIL. Science 276:111-113, 1997.
229. Parker, M. M., K. E. McCarthy, F. P. Ognibene, and J. E. Parillo. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126-131, 1990.
230. Parker, M. M., J. H. Shelhammer, S. L. Bacharach, M. V. Green, C. Natanson, T. M. Frederick, B. A. Damske, and J. E. Parillo. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100: 483-490, 1984.
231. Parmely, M. J., W. W. Zhou, C. K. Edwards, D. R. Borcherding, R. S. Silverstein, and D. C. Morrison. Adenosinc and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-a production and protect mice against endotoxin challenge. J. Immunol. 151:389-396, 1993.
232. Parrillo, J. E., C. Burch, J. H. Shelhammer, M. M. Parker, C. Natanson, and W. Schuette. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial performance. J. Clin. Invest. 76:1539-1553, 1985.
233. Pennica, D., K. L. King, and K. J. Shaw. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl.Acad. Sci. USA 92:1142-1146, 1995.
234. Peterson, S. M., C. T. Strzalka, J. A. Johnkoski, B. Noble, J. Gorfien, E. L. Hoover, and H. Bergsland. Combination of cyclosporine and splenectomy suppresses interleukin-6 production and major histocombatibility complex class II expression and prolongs cardiac xenograft survival. J. Thorac. Cardiovasc. Surg. 107:1001-1005, 1994.
235. Piot, C. P., D. Padmanaban, P. C. Ursell, R. E. Sievers, and C. L. Wolfe. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 96:1598-1604, 1997.
236. Plumier, J. L., B. M. ROSS, R. W. Currie, C. E. Angelidis, H. Kazlaris, G. Kollias, and G. N. Pagoulatos. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J. Clin. Invest. 95: 1854-1860, 1995.
237. Pugin, J., C. C. Schurer-Maly, D. Leureq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. Lipopolysaccharide (LPS) activation of human endothelial and epithelial cells is mediated by LPS binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-2748, 1993.
238. Reimann, T., D. Buscher, R. A. Hipskind, S. Krautwald, M. M. Lohmann, and M. Baccarini. Lipopolysaccharide induces activation of of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and TNF-alpha genes. J. Immunol. 153:5740-5749, 1994.
239. Ribeiro, S. P., J. Villar, G. P. Downey, J. D. Edelson, and A. S. Slutsky. Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages: evidence for TNF-a posttranslational regulation. Am. J. Respir. Crit. Care Med. 154:1843-1850, 1996.
240. Rowland, R. T., J. M. Brown, X. Meng, L. S. Terada, and A. H. Harken. The mechanism of immature myocardial tolerance to ischemia: phenotypic differences in antioxidants, stress proteins and oxidases. Surgery 118:446-452, 1995.
241. Rowland, R. T., J. C. Cleveland, X. Meng, A. H. Harken, and J. M. Brown. Potential gene therapy strategies in the treatment of cardiovascular disease. Ann. Thorac. Surg. 60: 721-728, 1995.
242. Ruddle, N. H., and B. H. Waksman. Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity. Science 157:1060-1062, 1967.
243. Sabbadini, R.A., R. Betto, A. Teresi, G. Fachechi-Cassano, and G. Salviati. The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J. Dial. Chetn. 267: 15475-15484, 1992.
244. Sadoff, J. Soluble TNF receptors. Third International Congress of the Immune Consequences of Trauma, Shock, and Sepsis. Munich, Germany, 1994.
245. Sanghera, J. S., S. L. Weinstein, M. Aluwalia, J. Girn, and S. L. Pelech. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J. Immunol. 156:4457-4465, 1996.
246. Saraste, A., K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L. M. Voipio-Pulkki. Apoptosis in human acute myocardial infarction. Circulation 95:320-323, 1997.
247. Sarih, M., V. Souvannavong, and A. Adam. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191:503-509, 1993.
248. Schluter, K. D., M. Weber, E. Schraven, and H. M. Piper. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1461-H1466, 1994.
249. Schmidt, K. N., E. B. Traenckner, B. Meier, and P. A. Baeuerle. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NFκB. J. Biol. Chem. 270: 27136-27142, 1995.
250. Schoenberg, M. H., B. Poch, D. Moch, M. Marzinzig, E. Marzinzig, T. Mattfeldt, H. Gruber, and H. G. Beger. Effect of acadesine treatment on postischemic damage to the small intestine. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1752-H1759, 1995.
251. Schulz, R., D. L. Panas, R. Catena, S. Moncada, P. M. Olley, and G. D. Lopaschuk. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor-a. Br. J. Pharmacol. 114:27-34, 1995.
252. Shakov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor-cc gene in primary macrophages. J. Exp. Med. 171:35-47, 1990.
253. Shapira, L., S. Takashiba, C. Champagne, S. Amar, and T. E. V. Dyke. Involvement of protein kinase C and protein tyrosine kinase in the lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human moncytes. J. Immunol. 153: 1818-1824, 1994.
254. Shapiro, L., and C. A. Dinarello. Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. USA 92: 12230-12234, 1995.
255. Shen, H. M., L. X. Sha, J. L. Kennedy, and D. W. Ou. Adrenergic receptors regulate macrophage secretion. Int. J. Immunopharmacol. 16:905-910, 1994.
256. Sheridan, B. C., R. C. Mclntyre, D. R. Meldrum, J. C. Cleveland, J. Agrafojo, J. H. Eisenach, A. H. Harken, and D. A. Fullerton. Antibody-mediated neutrophil depletion preserves pulmonary vasomotor function. J. Surg. Res. 62: 74-78, 1996.
257. Sherman, A. J., C. A. Davis, F. J. Klocke, K. R. Harris, G. Srinivasan, A. S. Yaacoub, D. A. Quinn, K. A. Ahlin, and J. J. Jang. Blockade of nitric oxide synthesis reduces myocardial oxygen consumption in vivo. Circulation 95: 1328-1334, 1997.
258. Sobotka, P.A., J. McMannis, R. I. Fisher, D. G. Stein, and J. X. Thomas. Effects of interleukin 2 on cardiac function in the isolated rat heart. J. Clin. Invest. 86:845-850, 1990.
259. Squadrito, F., D. Altavilla, B. Zingarelli, M. loculano, G. Calapai, G. M. Campo, A. Miceli, and A. P. Caputi. Tumor necrosis factor involvement in myoeadial ischaemia-reperfusion injury. Eur. J. Pharmacol. 237: 223-230, 1993.
260. Steenbergen, C., T. Fralix, and E. Murphy. Role of increased cytosolic calcium concentration in myocardial ischemic injury. Basic Res. Cardiol. 88:456-470, 1993.
261. Steenbergen, C., M. E. Perlman, R. E. London, and E. Murphy. Mechanism of preconditioning: ionic alterations. Circ. Res. 72:112-125, 1993.
262. Stein, B., P. Frank, W. Schmitz, H. Scholz, and M. Thoenes. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J. Mol. Cell. Cardiol. 28:1631-1639, 1996.
263. Steinshamn, S., M. H. Bemelmans, L. J. vanTits, K. Bergh, W. A. Buurman, and A. Waage. TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J. Immunol. 157: 2155-2159, 1996.
264. Steller, H. Mechanisms and genes of cellular suicide. Science 267:1445-1449, 1995.
265. Suzuki, K., Y. Sawa, Y. Kaneda, H. Ichikawa, R. Shirakura, and H. Matsuda. In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemiareperfusion injury in the rat. J. Clin. Invest. 99: 1645-1650, 1997.
266. Sweet, M. J., and D. A. Hume. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60: 8-26, 1996.
267. Szekeres, L., J. G. Papp, Z. Szilvâssy, E. Udvary, and A. Vegh. Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc. Res. 27: 593-596, 1993.
268. Tanaka, M., H. Ito, S. Adachi, T. Akimoto, T. Nishikawa, T. Kasajima, F. Marumo, and M. Hiroe. Hypoxia induces apoptosis with enhanced expression of fas antigen messenger RNA in cultured neonatal rat cardiorayocytes. Circ. Res. 75: 426-433, 1994.
269. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995.
270. Thornton, J., S. Striplin, G. S. Liu, A. Swafford, A. W. H. Stanley, D. M. Van Winkle, and J. M. Downey. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1822-H1825, 1990.
271. Thornton, J. D., G. S. Liu, R. A. Olsson, and J. M. Downey. Intravenous pretreatment with Al selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665, 1992.
272. Tong, L., S. Pav, D. M. White, S. Rogers, K. M. Crane, C. L. Cywin, M. L. Brown, and C. A. Pargellis. A highly specific inhibitor of human p38 kinase binds in the ATP pocket. Nat. Struct. Biol. 4:311-316, 1997.
273. Torre-Amione, G., S. Kapadia, C. Benedict, H. Oral, J. B. Young, and D. L. Mann. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J. Am. Coll. Cardiol. 27:1201-1206, 1996.
274. Torre-Amione, G., S. Kapadia, J. Lee, R. D. Bies, R. Lebovitz, and D. L. Mann. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92:1487-1493, 1995.
275. Torre-Amione, G., S. Kapadia, J. Lee, J. B. Durand, R. D. Bies, J. B. Young, and D. L. Mann. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711, 1996.
276. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474, 1986.
277. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. Anti-cachectin/ TNF monoclonal antibodies prevent septic shock during lethal bacteremia.Mztare 330: 662-664, 1987.
278. Trede, N. S., A. V. Tsytsykova, T. Chatila, A. E. Goldfeld, and R. S. Gehas. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NFi
279. Ulevitch, R. J., and P. S. Tobias. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457, 1995.
280. Ulich, T. R., M. J. Fann, P. H. Patterson, J. H. Williams, B. Samal, J. DelCastillo, S. Yin, K. Guo, and D. G. Remick. Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L442-L446, 1994.
281. Umansky, S. R., O. Pisarenko, L. Serebryakova, I. Studneva, O. Tsktishvilli, S. Khutzian, T. Sukhova, A. Lichtenstein, N. Ossina, and M. Kiefer. Dog cardiomyocyte death induced in vivo by ischemia and reperfusion. Basic Appl. Myol. 6:227-235, 1996.
282. Ungureanu-Longrois, D., J. L. Balligand, I. Okada, W. W. Simmons, L. Kobzik, C. J. Lowenstein, S. L. Kunkel, T. Michel, R. A. Kelly, and T. W. Smith. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to -adrenergic agonists. Circ. Res. 77:494-502, 1995.
283. Van, A. L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. Complex formation between Ras and Raf and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213-6217, 1993.
284. Vanderabeele, P., W. Deelereq, R. Beyaert, and W. Fiers. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-399, 1995.
285. VanderPoll, T., S. M. Coyle, K. Barbosa, C. C. Braxton, and S. F. Lowry. Epinephrine inhibits tumor necrosis factor-a and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97: 713-719, 1996.
286. VanHoffen, E., D. VanWichen, I. Stuij, N. DeJonge, C. Klopping, and J. Lahpor. In situ expression of cytokines in human heart alIograRs. Am. J. Pathol. 149:1991-2003, 1996.
287. VanZee, K. J., T. Kohno, E. Fisher, C. S. Rock, L. L. Moldawer, and S. F. Lowry. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factoralpha in vivo and in vitro. Proc. Natl. Acad. Sci. USA 89: 4845-4849, 1992.
288. Vaux, D. L., and A. Strasser. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93:2239-2244, 1996.
289. Wakabayashi, G., J. G. Cannon, J. A. Gelfand, B. D. Clark, K. Aiura, J. F. Burke, S. M. Wolffe, and C. A. Dinarello. Altered IL-1 and TNF production and secretion during pyrogenic tolerance to LPS in rabbits. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R329-R336, 1994.
290. Walker, D. M., and D. M. Yellon. Ischemic preconditioning: from mechanisms to exploitation. Cardiovasc. Res. 26:734-739, 1992.
291. Walker, G., D. Kunz, W. Pignat, H. vandenBosch, and J. Pfeilshifter. Pyrrolidine dithiocarbamate differentially affects cytokine- and cAMP-induced expression of group II phospholipase A2 in rat renal mesangial cells. FEES Lett. 8: 218-222, 1995.
292. Wan, S., J. M. DeSmet, L. Barvais, M. Golstein, J. L. Vincent, and J. L. LeClerc. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 112:806-811, 1996.
293. Wang, P., Z. Ba, D. R. Meldrum, and I. H. Chaudry. Diltiazem restores cardiac output and improves renal function ' following hemorrhage and resuscitation. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1435-H1440, 1992.
294. Wang, P., and J. L. Zweier. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271: 29223-29230, 1996.
295. Waring, P. M., L. J. Waring, T. Billington, and D. Metcalf. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc. Natl. Acad. Sci. USA 92:1337-1341, 1995.
296. Weil, M. H., L. D. MacLean, M. B. Visscher, and W. W. ' Spink. Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J. Clin. Invest. 35:1191-1198, 1956.
297. Weinstein, S. L., M. R. Gold, and A. L. DeFranco. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation : in macrophages. Proc. Natl. Acad. Sci. USA 88: 4148-4152, 1991.
298. Weinstein, S. L., C. H. June, and A. L. DeFranco. Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J. Immunol. 151: 3829-3838, 1993.
299. Weinstein, S. L., J. S. Sanghera, K. Lemke, A. L. DeFranco, and S. L. Pelech. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogenactivated protein kinases in macrophages. J. Biol. Chem. 267: 14955-14962, 1992.
300. Wherry, J., R. Wenzel, R. Wunderink, H. Silverman, T. Perl, and S. Nasraway. Monoclonal antibody to human tumor necrosis factor (TNF MAb): multicenter efficacy and safety study in patients with the sepsis syndrome. Thirty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, 1993.
301. Wiegman, K., S. Schutze, E. Kampen, A. Himmler, T. Machleidt, and M. Kronke. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol. Chem. 267:17997-18001, 1992.
302. Winter, C. B., J. C. Cleveland, K. L. Butler, D. B. Bensard, M. B. Mitchell, A. H. Harken, and A. Banerjee. Facilitative interactions between noradrenergic and purinergic signaling during preconditioning of the rat heart. J. Mol. Cell. Cardiol. 29:163-173, 1997.
303. Yellon, D. M., and G. F. Baxter. A second window of protection or delayed preconditioning: future horizons for myocardial protection? J. Mol. Cell. Cardiol. 27:1023-1034, 1995.
304. Yokoyama, T., M. Nakano, J. L. Bednarczyk, B. W. McIntyre, M. Entman, and D. L. Mann. Tumor necrosis factor-a provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95:1247-1252, 1997.
305. Yokoyama, T., L. Vaca, R. D. Rossen, W. Durante, P. Hazarika, and D. L. Mann. Cellular basis for the negative inotropic effects of tumor necrosis factor-ot in the adult mammalian cardiac myocyte. J. Clin. Invest. 92:2303-2312, 1993.
306. Yoshida, K., T. Taga, M. Saito, S. Suematsu, A. Kumanogoh, T. Tanaka, H. Fujiwara, M. Hirata, T. Yamagami, T. Nakahata, T. Hirabayashi, Y. Yoneda, K. Tanaka, W. Z. Wang, C. Mori, K. Shiota, N. Yoshida, and T. Kishimoto. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematologic disorders. Proc. Natl. Acad. Sci. USA 93: 407-411, 1996.
307. Zucchi, R., S. Ronca-Testoni, Y. Gongyuan, P. Galbani, G. Ronca, and M. Mariani. Postischemic changes in cardiac sarcoplasmic reticulum calcium channels: a possible mechanism of ischemic preconditioning. Circ. Res. 76: 1049-1056, 1995.
308. Zuckerman, S. H., G. F. Evans, and L. D. Butler. Endotoxin tolerance: Independent regulation of IL-1 and TNF expression. Infect. Immun. 41:2774-2780, 1991.